AUG 04, 2016 7:58 AM PDT

Toxin Found to be Responsible for Lethality of C. difficile Strain

WRITTEN BY: Carmen Leitch
 Hospital acquired infections are a serious public health concern. According to the Centers for Disease Control (CDC), the bacteria Clostridium difficile is estimated to have caused around half a million infections in the U.S. in 2011, and of those, 29,000 patients died within 30 days of diagnosis. The video below from Gastrointestinal Society has more information.
A new strain of C. difficile has been especially virulent, and new work done at the University of Virginia (UVA) shows that it’s a toxin - C. difficile transferase - secreted by the bacteria that’s responsible. The researchers also suggest a way to fight it. This strain of C. difficile has been of particular concern because it can kill up to 15 percent of patients that are infected with it even after antibiotic treatment, and it’s gotten more common in the past 15 years.
This micrograph depicts gram-positive Clostridium difficile bacteria from a stool sample culture obtained using a .1µm filter. / Credit: Janice Haney Carr, Centers for Disease Control and Prevention
The work, published in Nature Microbilogy, was done by Carrie A. Cowardin, then a PhD student working in the lab of Bill Petri, MD, PhD, the chief of UVA's Division of Infectious Diseases and International Health, in collaboration with international investigators. Cowardin discovered this strain produces a toxin that kills eosinophils in the gut. Stem cells in the bone marrow make eosinophils, which then migrate through the blood to peripheral sites. They localize primarily to the gastrointestinal tract, and remain there (in healthy people) as a normal part of the lining of the stomach, small intestine and colon. When they are destroyed, inflammation spreads through the body, which can be deadly, especially to vulnerable patients.

"We think that this toxin makes disease more severe by killing beneficial eosinophils, which seem to play an important role in promoting a healthy immune response during C. difficile infection. When the eosinophils were depleted with an antibody or by the toxin, we saw dramatically increased inflammation. Restoring eosinophils by transferring them from a mouse that cannot recognize the toxin prevented the damage inflicted by the epidemic strain," explained Cowardin, who is now a postdoctoral fellow at Washington University in St. Louis.

"This builds on previous work in our lab showing that eosinophils are beneficial and suggests that one reason this strain causes such severe disease is due to its ability to kill these cells."

Cowardin also uncovered the mechanism of action of the toxin. Apparently the toxin takes advantage of a specific human protein that can recognize bacteria; the protein is a critical part of the immune response. Thus, C. difficile gets around the natural defenses of the body. Revealing the mode of action of the toxin opens up the possibility of developing therapeutics to block it, and blocking the action of the toxin rescues the damage done to gut cells.

"Nearly every day that I care for patients I am faced with this potentially deadly infection," noted Petri. "Carrie Cowardin's discovery of why this strain of C. diff is so dangerous, and most importantly how to combat it, is a huge and most needed advance."
Image: Centers for Disease Control
This infographic from the CDC has some more information about C. difficile infection.

Sources: CDC, Phys.org via UVA, MedscapeNature Microbiology
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
DEC 01, 2019
Genetics & Genomics
DEC 01, 2019
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
JAN 14, 2020
Microbiology
JAN 14, 2020
Bacterial Growth That is Truly Cultured
Scientists have learned that when certain bacteria are paired together, they create patterns that look like flowers....
JAN 30, 2020
Genetics & Genomics
JAN 30, 2020
Genetically Engineered Bacteria Can Protect Bees From Pathogens
As pollinators, honey bees play a critical role in food production, and they have been suffering heavy losses for years....
FEB 13, 2020
Genetics & Genomics
FEB 13, 2020
A Very Unusual Virus is Discovered in Brazil
Researchers in Brazil have discovered a very unusual virus infecting amoeba in an artificial lake called Lake Pampulha in the city of Belo Horizonte....
FEB 05, 2020
Technology
FEB 05, 2020
Portable Device Detects Food-borne illness
 Foodborne illnesses kill 3,000 people on an annual basis. According to the Centers for Disease Control and Prevention, an estimated 48 million people...
Loading Comments...